Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,358 GBX | +0.21% | +2.46% | +16.47% |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.47% | 239B | |
+32.36% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+8.11% | 204B | |
-7.44% | 198B | |
+8.62% | 168B | |
+4.62% | 125B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- European Markets Advance as Germany Eases Recession Fears